Replication-defective vector based on a chimpanzee adenovirus.
about
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapyProtection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunizationStructural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methodsDevelopment of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based ConstructsCircumventing antivector immunity: potential use of nonhuman adenoviral vectorsA global approach to HIV-1 vaccine developmentOvercoming immunity to a viral vaccine by DNA priming before vector boostingA novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicityVaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionalityProduction of adenovirus vectors and their use as a delivery system for influenza vaccines.Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus.Adenoviral vectors as novel vaccines for influenza.Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine.A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice.Yeast Surface-Displayed H5N1 Avian Influenza Vaccines.Adenoviral vector immunity: its implications and circumvention strategies.The influence of innate and pre-existing immunity on adenovirus therapyA novel oncolytic adenovirus based on simian adenovirus serotype 24Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease: implications for gene therapy and vaccine vector development.Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunityReplicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.Development of a targeted gene vector platform based on simian adenovirus serotype 24.Assessment of route of administration and dose escalation for an adenovirus-based influenza A Virus (H5N1) vaccine in chickensModification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responsesNovel adenovirus vector-based vaccines for HIV-1.Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.Preexisting immunity to adenovirus in rhesus monkeys fails to prevent vector-induced toxicity.Current progress in the development of a prophylactic vaccine for HIV-1.Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques.Current strategies and future directions for eluding adenoviral vector immunityNew hope for an AIDS vaccine.Challenges in the development of an HIV-1 vaccine.Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.Genetic medicine strategies to protect against bioterrorism.International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsHuman immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypesImmunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunityAntigen expression determines adenoviral vaccine potency independent of IFN and STING signaling.
P2860
Q24535690-D6918614-3F0B-49E3-A72B-6B7E08E09769Q24538818-3F354C3F-9124-4F63-8FAF-2A5E0F2F4F07Q24683349-1A17BF52-AA23-4A5A-B256-2BEEC8FCF864Q26782083-55C07BBA-66A5-4D80-9461-DFD6A50B8BA4Q26995655-B4B7DECB-4C82-424B-A57E-62520CDAB5BEQ27024614-8DC39E19-F7A5-41EA-A041-42C4BED57D7BQ28217213-037B7D86-D273-4ABC-97C4-FEF0B2DD67B1Q28727030-1E5FF667-85A5-4F26-9161-13109227F700Q28744027-75BE38BB-2456-4C99-9C39-2BEF69BC3759Q30226988-78DCE5F0-2751-4BD7-AAF8-574C64B2CEAFQ30229074-6222AE65-B1DF-4850-8967-37CD80531748Q30370445-A3DFC151-C79E-4EE4-91F4-EDCE49E40236Q30378897-E9C0D230-B8CC-4DDA-A2C1-CEDA13A5FED9Q30389068-CCA77F3D-F8C3-4A32-9AE1-AD2434162FA4Q30397351-7DAD6C1F-AAC5-41DB-8405-920D01669C25Q33565630-5D20BD11-93D8-479C-A3DE-08674579C5C7Q33655401-D64ADABB-4A7E-48AB-BD28-6A6AF570DE13Q33688856-36E3A9A8-69E7-42B1-94B5-29D9C6D1865BQ33781719-1A8BF42B-A4CD-4708-8169-93F60E2E82C4Q33908767-F1BD8739-B9BF-47B4-B728-DE00B7C3648FQ33911986-2312E01C-2D8D-4C16-B488-A6D7EEC946E0Q34033557-8DB31E4A-2572-4E41-948C-FF5CB8D6D22CQ34120794-21D5C156-12FD-4E7C-AB5E-CA1A419233D4Q34150488-51B2894D-1B9B-4A9B-9906-918E73843D48Q34229968-763BE5A3-E921-4BFA-8CFD-9E285BFA0D35Q34257640-1399B53A-985E-43A1-A539-B4F4012E8E41Q34332885-A8E89C1B-1640-4EEA-ACD2-EA8E8D7604D2Q34365087-DA450396-2306-428D-8BC7-8D3833A57D4CQ34502108-D1743086-7026-4D24-937E-E8629BD86B89Q34556871-2F509974-6EB0-4DFD-98BD-BBC30692B063Q34585554-8CA2D03C-CEE5-4841-8A6C-05C904954D08Q34632063-8913EA1D-B41B-4B74-9840-C1178EB4F9D1Q34657290-1145C80D-B8F4-4993-AEB8-032C58B2E778Q34701517-187F7DCB-0CE8-4805-BDDD-7C6DE8B16EEAQ34767181-E107CA3C-3352-4800-8C00-25CA47451AB6Q35112755-30D08631-C94D-4495-9AAF-76D3F2C50E8AQ35123692-4FE45FAF-2096-4278-A00D-26F45C76563BQ35131227-256A7517-202E-46FF-89DB-344FDBCAF6D4Q35155049-4AABD72F-8CB2-4916-B695-E04EE8E13545Q35183935-9789054E-8C72-4C2B-A367-7A8B779CC0EF
P2860
Replication-defective vector based on a chimpanzee adenovirus.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Replication-defective vector based on a chimpanzee adenovirus.
@en
Replication-defective vector based on a chimpanzee adenovirus.
@nl
type
label
Replication-defective vector based on a chimpanzee adenovirus.
@en
Replication-defective vector based on a chimpanzee adenovirus.
@nl
prefLabel
Replication-defective vector based on a chimpanzee adenovirus.
@en
Replication-defective vector based on a chimpanzee adenovirus.
@nl
P2093
P2860
P1433
P1476
Replication-defective vector based on a chimpanzee adenovirus.
@en
P2093
J M Wilson
M R Alvira
R M Burnett
S F Farina
P2860
P304
11603-11613
P356
10.1128/JVI.75.23.11603-11613.2001
P407
P577
2001-12-01T00:00:00Z